C96.20 — Malignant mast cell neoplasm, unspecified
C96.20 is a billable, specific ICD-10-CM code for malignant mast cell neoplasm, unspecified. It is valid for submission on a claim.
Risk adjustment
C96.20 risk-adjusts. Under the CMS-HCC V28 model it maps to this category:
- HCC 21 Lymphoma and Other Cancers0.671 RAF
Coefficient shown for the Community Non-dual Aged segment. A higher HCC in the same hierarchy will suppress this one, so capturing it does not always add score.
Medicare coverage
C96.20 is named in 33 Medicare coverage policies — 33 listing it as supporting medical necessity. Which of them applies to you depends on your Medicare contractor, and coverage genuinely differs by state.
- A52986Billing and Coding: Biomarkers for Oncology
- A54768Billing and Coding: Cardiac Blood Pool Imaging (Multiple Gated Acquisition Scanning- MUGA, Ventriculography) When Performed in Conjunction with Cardiotoxic Chemotherapy
- A55717Billing and Coding: Lab: Flow Cytometry
- A56199Billing and Coding: Molecular Pathology Procedures
How C96.20 is indexed
Coders do not find codes by browsing the tabular list — they look them up in the alphabetic index, under the word the physician wrote. These are the index entries that lead here, so you can see which chart wordings map to C96.20.
- Neoplasm, neoplastic›malignant mast cell
- Mast cell›neoplasm›malignant
Related codes at this level
Codes that share C96.2. If C96.20 is not quite right, the correct code is usually one of these.
Questions about C96.20
- Is C96.20 a billable ICD-10-CM code?
- Yes. C96.20 is a billable, specific ICD-10-CM code and is valid for submission on a claim.
- Where does C96.20 sit in the tabular list?
- Neoplasms (C00-D49), in the block Malignant neoplasms of lymphoid, hematopoietic and related tissue (C81-C96).